BB Healthcare Trust PLC Issue of Equity (7166S)
July 10 2020 - 10:36AM
UK Regulatory
TIDMBBH
RNS Number : 7166S
BB Healthcare Trust PLC
10 July 2020
10 July 2020
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR
INDIRECTLY, TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC
OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN
THE UNITED KINGDOM) OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE
UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM
OR TO PROFESSIONAL INVESTORS IN IRELAND)
BB Healthcare Trust plc
Issue of Ordinary Shares
BB Healthcare Trust plc (the "Company") announces that it has
today issued 500,000 of its ordinary shares of one penny each
("Ordinary Shares") pursuant to its block listing facility. The
Ordinary Shares will be issued at a price of 168.02 pence per
Ordinary Share, a premium to the prevailing net asset value (cum
income) per Ordinary Share.
Following the issue of Ordinary Shares, the Company's issued
share capital will comprise 462,250,000 Ordinary Shares and this is
the total number of Ordinary Shares with voting rights in the
Company. This figure (462,250,000) may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to,
their interest in the Company under the Financial Conduct
Authority's Disclosure Guidance and Transparency Rules.
The Company's LEI is: 213800HQ3J3H9YF2UI82
For further information please contact:
Peel Hunt LLP
Liz Yong, Tom Pocock (Corporate Broking)
Alex Howe, Ed Welsby (Sales)
Telephone: +44 (0) 207 418 8900
J.P. Morgan Cazenove
James Bouverat (Sales)
Telephone: +44 (0) 207 134 2224
Bellevue Asset Management (UK) Ltd.
Mark Ghahramani
Telephone: +44 (0) 203 326 2981
Disclaimer
This announcement does not constitute a prospectus relating to
the Company and does not constitute, or form part of, any offer or
invitation to sell or issue, or any solicitation of any offer to
purchase or subscribe for, any shares in the Company in any
jurisdiction nor shall it, or any part of it, or the fact of its
distribution, form the basis of, or be relied on in connection with
or act as any inducement to enter into, any contract therefor.
Peel Hunt LLP ("Peel Hunt") and J.P. Morgan Cazenove, which are
authorised and regulated by the Financial Conduct Authority, are
acting for the Company only in connection with the matters
described in this announcement and are not acting for or advising
any other person, or treating any other person as their client, in
relation thereto and will not be responsible for providing the
regulatory protection afforded to clients of Peel Hunt and J.P.
Morgan Cazenove or advice to any other person in relation to the
matters contained herein.
The shares of the Company have not been and will not be
registered under the US Securities Act of 1933, and may not be
offered or sold in the United States absent registration or an
applicable exemption from the registration requirements. Moreover,
the shares of the Company have not been, nor will they be,
registered under the applicable securities laws of Australia,
Canada, the Republic of South Africa, Japan or any member state of
the EEA (other than the United Kingdom). Further, the Company will
not be registered under the US Investment Company Act of 1940, as
amended. Subject to certain exceptions, the shares of the Company
may not be offered or sold in the United States, Australia, Canada,
the Republic of South Africa, Japan or any member state of the EEA
(other than the United Kingdom or to professional investors in
Ireland) or to, or for the account or benefit of, any national,
resident or citizen of the United States, Australia, Canada, the
Republic of South Africa, Japan or any member state of the EEA
(other than the United Kingdom or to professional investors in
Ireland). The share issuance programme, and the distribution of
this announcement, in other jurisdictions may be restricted by law
and the persons into whose possession this announcement comes
should inform themselves about, and observe, any such
restrictions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOEFLFVEDEIILII
(END) Dow Jones Newswires
July 10, 2020 11:36 ET (15:36 GMT)
Bellevue Healthcare (LSE:BBH)
Historical Stock Chart
From Apr 2024 to May 2024
Bellevue Healthcare (LSE:BBH)
Historical Stock Chart
From May 2023 to May 2024